Mylan Pharmaceuticals

Activities: Drug Delivery Pharmaceutical

Resources and information to help prescribers, dispensers and patients be confident about their medicine

Trending Articles

  1. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  2. Catalent Boston adds to oral spray drying capacity to support late-stage clinical trials and commercialisation Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies and flexible manufacturing, has completed a series of upgrades to its...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  4. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human...
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Finance

Mylan chooses Beximco for exclusive antibody distribution in Bangladesh

Beximco Pharma has received the exclusive rights to launch Netherlands-based Mylan’s portfolio of key monoclonal antibodies in its headquarters of Bangladesh
Regulatory

Biocon biologics facility gets FDA nod

India's biopharmaceutical giant has been investing in expanding manufacturing capacity in line with expectations of higher biosimilars penetration in developed and emerging market
Finance

Pfizer and Mylan to launch new global pharmaceutical company

Upjohn, Pfizer’s off-patent branded and generic business, will merge with Mylan
Drug Delivery

Mylan and Hospira voluntarily recall injectables

Glass and copper salts were found in the companies’ injectable medications but no adverse reactions have been reported as yet
Media

Global market for inhaled drugs rapidly growing

As incidences of diseases such as COPD and asthma rise, so too does the global demand for inhaled drugs, especially those using innovative new delivery technologies
Research & Development

Mylan to acquire Renaissance's speciality and generic topical business

Mylan is acquiring the business on a cash-free, debt-free basis and expects to finance the transaction using a combination of cash and available borrowings under existing credit facilities
Regulatory

Delhi High Court puts restrictions on Biocon and Mylan breast cancer drug marketing

Court allowed the sale and manufacture of affordable cancer drugs by Biocon and Mylan with certain restrictions on packaging and labelling and regulatory process
Subscribe now